CSPG4 and glioblastoma: CSPG4 (MCSP), expressed in mesenchymal cells, is linked to stem cell renewal, tumor recurrence, and drug resistance and plays a key role in GBM progression through interactions with the ECM and angiogenesis, also contributing to multidrug resistance via PI3K pathway activation [80,81].